CD4 and Opportunistic infection: This is in agreement with WHO and other guidelines.(88–91) A range has been given based on expert opinion and clinicians should decide to start ART based on individual patient factors, considering CD4 count (if available), other opportunistic infections, neuroimaging and TBM-IRIS risk factors (CSF ZN/culture positivity, CSF neutrophil pleocytosis).(92)